Gold
Compare Stocks
5 / 10Stock Comparison
NEM vs LIN vs ALB vs ECL vs SHW
Revenue, margins, valuation, and 5-year total return — side by side.
Chemicals - Specialty
Chemicals - Specialty
Chemicals - Specialty
Chemicals - Specialty
NEM vs LIN vs ALB vs ECL vs SHW — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Gold | Chemicals - Specialty | Chemicals - Specialty | Chemicals - Specialty | Chemicals - Specialty |
| Market Cap | $125.72B | $228.85B | $23.37B | $72.46B | $78.98B |
| Revenue (TTM) | $17.23B | $34.66B | $5.49B | $16.08B | $23.94B |
| Net Income (TTM) | $5.26B | $7.13B | $-233M | $2.08B | $2.60B |
| Gross Margin | 52.1% | 46.0% | 18.5% | 44.5% | 49.1% |
| Operating Margin | 49.3% | 28.8% | 5.6% | 17.7% | 16.1% |
| Forward P/E | 10.9x | 27.7x | 22.4x | 30.6x | 27.3x |
| Total Debt | $474M | $26.99B | $3.30B | $9.43B | $14.53B |
| Cash & Equiv. | $7.65B | $5.06B | $1.62B | $646M | $207M |
NEM vs LIN vs ALB vs ECL vs SHW — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Newmont Corporation (NEM) | 100 | 194.1 | +94.1% |
| Linde plc (LIN) | 100 | 244.1 | +144.1% |
| Albemarle Corporati… (ALB) | 100 | 259.2 | +159.2% |
| Ecolab Inc. (ECL) | 100 | 120.7 | +20.7% |
| The Sherwin-William… (SHW) | 100 | 161.8 | +61.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: NEM vs LIN vs ALB vs ECL vs SHW
Each card shows where this stock fits in a portfolio — not just who wins on paper.
NEM carries the broadest edge in this set and is the clearest fit for growth exposure and sleep-well-at-night.
- Rev growth 19.1%, EPS growth 124.1%, 3Y rev CAGR 22.7%
- Lower volatility, beta 0.75, Low D/E 1.4%, current ratio 1.72x
- PEG 0.85 vs SHW's 3.94
- 19.1% revenue growth vs ALB's -4.4%
LIN is the #2 pick in this set and the best alternative if income & stability and long-term compounding is your priority.
- Dividend streak 6 yrs, beta 0.24, yield 1.2%
- 375.2% 10Y total return vs NEM's 293.1%
- Beta 0.24, yield 1.2%, current ratio 0.88x
- Beta 0.24 vs ALB's 1.60
ALB ranks third and is worth considering specifically for momentum.
- +256.7% vs SHW's -8.0%
Among these 5 stocks, ECL doesn't own a clear edge in any measured category.
SHW is the clearest fit if your priority is efficiency.
- 10.0% ROA vs ALB's -1.4%, ROIC 16.5% vs 0.6%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 19.1% revenue growth vs ALB's -4.4% | |
| Value | Lower P/E (10.9x vs 27.3x), PEG 0.85 vs 3.94 | |
| Quality / Margins | 30.5% margin vs ALB's -4.2% | |
| Stability / Safety | Beta 0.24 vs ALB's 1.60 | |
| Dividends | 1.2% yield, 6-year raise streak, vs SHW's 1.0% | |
| Momentum (1Y) | +256.7% vs SHW's -8.0% | |
| Efficiency (ROA) | 10.0% ROA vs ALB's -1.4%, ROIC 16.5% vs 0.6% |
NEM vs LIN vs ALB vs ECL vs SHW — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
NEM vs LIN vs ALB vs ECL vs SHW — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
NEM leads in 4 of 6 categories
LIN leads 1 • ALB leads 0 • ECL leads 0 • SHW leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
NEM leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
LIN is the larger business by revenue, generating $34.7B annually — 6.3x ALB's $5.5B. NEM is the more profitable business, keeping 30.5% of every revenue dollar as net income compared to ALB's -4.2%. On growth, ALB holds the edge at +32.7% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $17.2B | $34.7B | $5.5B | $16.1B | $23.9B |
| EBITDAEarnings before interest/tax | $12.7B | $12.1B | $802M | $3.5B | $4.5B |
| Net IncomeAfter-tax profit | $5.3B | $7.1B | -$233M | $2.1B | $2.6B |
| Free Cash FlowCash after capex | $12.9B | $5.1B | $577M | $1.9B | $2.9B |
| Gross MarginGross profit ÷ Revenue | +52.1% | +46.0% | +18.5% | +44.5% | +49.1% |
| Operating MarginEBIT ÷ Revenue | +49.3% | +28.8% | +5.6% | +17.7% | +16.1% |
| Net MarginNet income ÷ Revenue | +30.5% | +20.6% | -4.2% | +12.9% | +10.9% |
| FCF MarginFCF ÷ Revenue | +75.0% | +14.7% | +10.5% | +11.8% | +12.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | -100.0% | +8.2% | +32.7% | +4.8% | +6.8% |
| EPS Growth (YoY)Latest quarter vs prior year | -100.0% | +13.4% | — | +19.3% | +7.5% |
Valuation Metrics
NEM leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 17.7x trailing earnings, NEM trades at a 50% valuation discount to ECL's 35.2x P/E. Adjusting for growth (PEG ratio), LIN offers better value at 1.33x vs SHW's 4.51x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $125.7B | $228.8B | $23.4B | $72.5B | $79.0B |
| Enterprise ValueMkt cap + debt − cash | $118.6B | $250.8B | $25.1B | $81.2B | $93.3B |
| Trailing P/EPrice ÷ TTM EPS | 17.70x | 33.85x | -34.50x | 35.24x | 31.18x |
| Forward P/EPrice ÷ next-FY EPS est. | 10.89x | 27.67x | 22.36x | 30.64x | 27.27x |
| PEG RatioP/E ÷ EPS growth rate | 1.38x | 1.33x | — | — | 4.51x |
| EV / EBITDAEnterprise value multiple | 9.03x | 19.75x | 33.21x | 22.66x | 21.24x |
| Price / SalesMarket cap ÷ Revenue | 5.69x | 6.73x | 4.55x | 4.51x | 3.35x |
| Price / BookPrice ÷ Book value/share | 3.69x | 5.82x | 2.39x | 7.46x | 17.33x |
| Price / FCFMarket cap ÷ FCF | 17.22x | 44.97x | 33.76x | 38.05x | 29.76x |
Profitability & Efficiency
NEM leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
SHW delivers a 58.2% return on equity — every $100 of shareholder capital generates $58 in annual profit, vs $-2 for ALB. NEM carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to SHW's 3.16x. On the Piotroski fundamental quality scale (0–9), NEM scores 9/9 vs ECL's 5/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +15.6% | +17.8% | -2.3% | +22.0% | +58.2% |
| ROA (TTM)Return on assets | +9.4% | +8.3% | -1.4% | +8.8% | +10.0% |
| ROICReturn on invested capital | +24.9% | +11.3% | +0.6% | +12.7% | +16.5% |
| ROCEReturn on capital employed | +20.7% | +13.0% | +0.6% | +15.8% | +21.3% |
| Piotroski ScoreFundamental quality 0–9 | 9 | 6 | 6 | 5 | 6 |
| Debt / EquityFinancial leverage | 0.01x | 0.68x | 0.34x | 0.96x | 3.16x |
| Net DebtTotal debt minus cash | -$7.2B | $21.9B | $1.7B | $8.8B | $14.3B |
| Cash & Equiv.Liquid assets | $7.6B | $5.1B | $1.6B | $646M | $207M |
| Total DebtShort + long-term debt | $474M | $27.0B | $3.3B | $9.4B | $14.5B |
| Interest CoverageEBIT ÷ Interest expense | 50.54x | 34.52x | 1.59x | 9.82x | 7.83x |
Total Returns (Dividends Reinvested)
NEM leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in NEM five years ago would be worth $17,998 today (with dividends reinvested), compared to $11,612 for SHW. Over the past 12 months, ALB leads with a +256.7% total return vs SHW's -8.0%. The 3-year compound annual growth rate (CAGR) favors NEM at 34.3% vs ALB's 3.0% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +12.4% | +15.5% | +38.1% | -2.0% | -2.1% |
| 1-Year ReturnPast 12 months | +112.0% | +11.2% | +256.7% | +2.0% | -8.0% |
| 3-Year ReturnCumulative with dividends | +142.1% | +39.7% | +9.3% | +52.7% | +42.4% |
| 5-Year ReturnCumulative with dividends | +80.0% | +73.9% | +26.8% | +17.3% | +16.1% |
| 10-Year ReturnCumulative with dividends | +293.1% | +375.2% | +217.0% | +139.5% | +250.0% |
| CAGR (3Y)Annualised 3-year return | +34.3% | +11.8% | +3.0% | +15.2% | +12.5% |
Risk & Volatility
LIN leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
LIN is the less volatile stock with a 0.24 beta — it tends to amplify market swings less than ALB's 1.60 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. LIN currently trades 94.7% from its 52-week high vs ECL's 83.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.75x | 0.24x | 1.60x | 0.63x | 0.79x |
| 52-Week HighHighest price in past year | $134.88 | $521.28 | $221.00 | $309.27 | $379.65 |
| 52-Week LowLowest price in past year | $48.27 | $387.78 | $53.70 | $249.04 | $301.58 |
| % of 52W HighCurrent price vs 52-week peak | +84.1% | +94.7% | +89.8% | +83.0% | +84.3% |
| RSI (14)Momentum oscillator 0–100 | 53.5 | 51.7 | 53.0 | 46.0 | 47.6 |
| Avg Volume (50D)Average daily shares traded | 9.2M | 2.3M | 2.0M | 1.4M | 1.6M |
Analyst Outlook
Evenly matched — LIN and SHW each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: NEM as "Buy", LIN as "Buy", ALB as "Hold", ECL as "Buy", SHW as "Buy". Consensus price targets imply 27.5% upside for ECL (target: $327) vs -3.8% for ALB (target: $191). For income investors, LIN offers the higher dividend yield at 1.21% vs ALB's 0.82%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Hold | Buy | Buy |
| Price TargetConsensus 12-month target | $137.50 | $539.71 | $190.80 | $327.11 | $389.43 |
| # AnalystsCovering analysts | 36 | 28 | 45 | 37 | 38 |
| Dividend YieldAnnual dividend ÷ price | +0.9% | +1.2% | +0.8% | +1.0% | +1.0% |
| Dividend StreakConsecutive years of raises | 1 | 6 | 15 | 12 | 37 |
| Dividend / ShareAnnual DPS | $1.00 | $6.00 | $1.62 | $2.64 | $3.17 |
| Buyback YieldShare repurchases ÷ mkt cap | +1.8% | +2.0% | 0.0% | +1.1% | 0.0% |
NEM leads in 4 of 6 categories (Income & Cash Flow, Valuation Metrics). LIN leads in 1 (Risk & Volatility). 1 tied.
NEM vs LIN vs ALB vs ECL vs SHW: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is NEM or LIN or ALB or ECL or SHW a better buy right now?
For growth investors, Newmont Corporation (NEM) is the stronger pick with 19.
1% revenue growth year-over-year, versus -4. 4% for Albemarle Corporation (ALB). Newmont Corporation (NEM) offers the better valuation at 17. 7x trailing P/E (10. 9x forward), making it the more compelling value choice. Analysts rate Newmont Corporation (NEM) a "Buy" — based on 36 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — NEM or LIN or ALB or ECL or SHW?
On trailing P/E, Newmont Corporation (NEM) is the cheapest at 17.
7x versus Ecolab Inc. at 35. 2x. On forward P/E, Newmont Corporation is actually cheaper at 10. 9x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Newmont Corporation wins at 0. 85x versus The Sherwin-Williams Company's 3. 94x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — NEM or LIN or ALB or ECL or SHW?
Over the past 5 years, Newmont Corporation (NEM) delivered a total return of +80.
0%, compared to +16. 1% for The Sherwin-Williams Company (SHW). Over 10 years, the gap is even starker: LIN returned +375. 2% versus ECL's +139. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — NEM or LIN or ALB or ECL or SHW?
By beta (market sensitivity over 5 years), Linde plc (LIN) is the lower-risk stock at 0.
24β versus Albemarle Corporation's 1. 60β — meaning ALB is approximately 565% more volatile than LIN relative to the S&P 500. On balance sheet safety, Newmont Corporation (NEM) carries a lower debt/equity ratio of 1% versus 3% for The Sherwin-Williams Company — giving it more financial flexibility in a downturn.
05Which is growing faster — NEM or LIN or ALB or ECL or SHW?
By revenue growth (latest reported year), Newmont Corporation (NEM) is pulling ahead at 19.
1% versus -4. 4% for Albemarle Corporation (ALB). On earnings-per-share growth, the picture is similar: Newmont Corporation grew EPS 124. 1% year-over-year, compared to -2. 7% for The Sherwin-Williams Company. Over a 3-year CAGR, NEM leads at 22. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — NEM or LIN or ALB or ECL or SHW?
Newmont Corporation (NEM) is the more profitable company, earning 32.
1% net margin versus -9. 9% for Albemarle Corporation — meaning it keeps 32. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NEM leads at 46. 9% versus 1. 8% for ALB. At the gross margin level — before operating expenses — NEM leads at 49. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is NEM or LIN or ALB or ECL or SHW more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Newmont Corporation (NEM) is the more undervalued stock at a PEG of 0. 85x versus The Sherwin-Williams Company's 3. 94x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Newmont Corporation (NEM) trades at 10. 9x forward P/E versus 30. 6x for Ecolab Inc. — 19. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ECL: 27. 5% to $327. 11.
08Which pays a better dividend — NEM or LIN or ALB or ECL or SHW?
All stocks in this comparison pay dividends.
Linde plc (LIN) offers the highest yield at 1. 2%, versus 0. 8% for Albemarle Corporation (ALB).
09Is NEM or LIN or ALB or ECL or SHW better for a retirement portfolio?
For long-horizon retirement investors, Linde plc (LIN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
24), 1. 2% yield, +375. 2% 10Y return). Albemarle Corporation (ALB) carries a higher beta of 1. 60 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (LIN: +375. 2%, ALB: +217. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between NEM and LIN and ALB and ECL and SHW?
Both stocks operate in the Basic Materials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: NEM is a mid-cap high-growth stock; LIN is a large-cap quality compounder stock; ALB is a mid-cap quality compounder stock; ECL is a mid-cap quality compounder stock; SHW is a mid-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.